Veterinary Artificial Insemination Market Size, Share & Trends Report

Veterinary Artificial Insemination Market Size, Share & Trends Analysis Report By Animal Type (Cattle, Swine, Sheep, Canine, Equine, Others), By Product (Normal Semen, Sexed Semen), By End-use, By Region, And Segment Forecasts, 2020 - 2027

  • Published Date: Aug, 2020
  • Base Year for Estimate: 2019
  • Report ID: GVR-3-68038-570-0
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2018
  • Number of Pages: 145

Report Overview

The global veterinary artificial insemination market size was valued at USD 3.79 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 5.78% from 2020 to 2027. The technique has been commercially available for over 60 years and has been utilized very effectively in the cattle and dairy industry. Various factors such as artificial insemination (AI) can reduce many of the risks involved with animal breeding and disease transmission are the major factors leading to market growth. Increasing productivity using AI technology is boosting the market. Female offspring born through artificial insemination are found to produce more milk than normal offspring. The use of semen extenders containing antibiotics is also helpful in preventing the transmission of bacterial diseases. Furthermore, the entire procedure of AI is considered to be much more hygienic than natural mating.

U.S. veterinary artificial insemination market size

Moreover, as the production conditions and the farmers' needs evolve, many of the animal breeds are no longer suitable for the majority of farms. However, artificial insemination is used as a preferred reproduction method for such breeds and makes it possible to continue to farm the breeds in situ. Increasing human population is also a major factor leading to the continuous need for growing animal productivity. Moreover, associated advantages such as increased efficiency of bull usage, genetic selection, decreased cost of housing, handling bull, and safety for farmers & animals is further anticipated to increase adoption of AI in the coming years. Increasing calf prices is also major factor farmers are adopting AI technology. According to a report published by the Beef Cattle Research Council in March 2018, bull prices were USD 5,500 to USD 8,000 in Canada from 2015 to 2016. These prices decreased to USD 4,500 to USD 6,500 from 2017 to 2018 owing to the adoption of AI.

The demand for the genetically superior breed of animals is increasing, which in turn is increasing the demand for artificial insemination procedures in animals. The industry players are continuously trying to develop new products along with partnerships, collaboration, and acquisitions to sustain their market share. For instance, in August 2020, Cogent collaborated with AB Europe, a sheep breeding company, to launch a novel sexed semen service for sheep producers in the UK. In May 2018, Recombinetics partnered with SEMEX for the implementation of a precision breeding program that improved animal health & well-being through hornless dairy cattle genetics.

Animal Type Insights

Based on live animal Products, the cattle segment commanded the largest share of 46.5% in 2019. Increased adoption of cattle for artificial insemination procedures, rising milk consumption, and production of beef are factors responsible for the significant growth of the veterinary artificial insemination market. For instance, according to data published by the UN FAO in 2018, beef & buffalo production increased from 69.56 million tons in 2017 to 71.61 million tons in 2018. Furthermore, the rising consumption of milk and milk products is positively impacting the market growth.

Equine AI is anticipated to grow at a lucrative rate over the forecast period. The growth can be attributed to reducing the risk of disease transmission and increasing productivity using AI, which is increasing the adoption. Moreover, the protection of endangered species by artificial insemination is further propelling the market. Disease transmission risks also got reduced using AI technology. The aforementioned factors are expected to propel the growth in the coming years.

Product Insights

Based on Product, the normal semen segment commanded the largest market share of 76% in 2019 and is expected to maintain its position during the forecast period. The high segmental revenue is attributed to the low price of the normal semen as compared to sexed semen. For instance, according to a study published by the Italian Journal of Animal Science in May 2017, the conception rate of sexed semen as a percentage of normal semen ranged from 71.8% to 78.5%, which was indicative that normal semen had a higher fertility rate than sexed semen.

Sexed semen is expected to show the fastest growth over the forecast period. Sexed semen technology is relatively new and is being adopted to increase the rate of herd expansion. It has reliable effects on the gender of the offspring. Sexed semen was commercialized in 2001 in the U.S. and license was granted to Sexing Technologies. Factors such as consolidation of elite breeding herds, adoption of the latest technology, and high consumption of animal protein are driving the growth of the sexed semen segment.

End-use Insights

Based on end-use, the animal husbandry segment commanded the maximum market share of around 46% in 2019. The growth can be attributed to the majority of the semen collection and AI procedures are performed in small and large breeding farms. Moreover, increasing government initiatives and demand for milk and protein is further increasing the adoption of AI technology. For instance, in October 2018 Indian government approved around USD 330 million for Animal husbandry Infrastructure Development Fund (AHIDF). In February 2018, Alibaba Cloud, DEKON Group, and Sichuan Tequ Group collaborated to use ET Brain technology for pig breeding in China.

Global veterinary artificial insemination market share

Veterinary Hospitals also held a considerable share of the veterinary AI market as of 2019. An increasing number of hospitals carrying out artificial insemination procedures in developed & developing countries and rising number of veterinarians are factors driving the market. Other end-users of the market include veterinary clinics, private veterinarians carrying out artificial insemination procedures in farms. Veterinarians in the developing countries provide home services and government regulations are supportive in these countries which are boosting the growth. For instance, as per the AI Development Plan launched in 2017 in China, the Chinese government describes artificial insemination as a new focal point of international competition and declared itself open to a world’s premier AI innovation center by 2030.

Regional Insights

Asia Pacific held the largest market share of 30.3% of the veterinary AI market owing to the presence of a huge livestock population in this region. Increasing demand for milk and animal-based protein along with government initiatives are propelling the market growth. India held a revenue share of around 24.4% of the Asia Pacific market as of 2019. For instance, in May 2020 Indian government announced USD 2.13 billion funds for animal husbandry infrastructure development projects. Moreover, China also has the third-largest cattle inventory and actively performing artificial insemination technology in farms to increase productivity which is boosting the revenue.

Latin America also held a considerable share of the market as of 2019. Brazil is one of the major countries in this region where the technique has been utilized effectively. Herds in some countries including Brazil have implemented fixed-time artificial insemination (FTAI) techniques to leverage their profits. The U.S. is another country where almost 90% of the milk-producing cattle population utilize artificial insemination. For instance, according to the Brazilian Association of Artificial Insemination, commercialized semen doses increased from 7 million in 2003 to nearly 14 million in 2017.

Key Companies & Market Share Insights

The market for veterinary artificial insemination is highly fragmented in nature. The product portfolio varies from frozen semen, fresh semen, sexed semen, semen storage services, and others. The continuous demand from the food industry is further propelling the market growth for genetically modified animals to increase productivity. The leading players are involved in new product launch, collaborations, mergers & acquisitions, and regional expansions to gain maximum revenue share in the sector. New diseases resistant breed development help companies to expand their existing portfolio of animal genetic and geographical reach. For instance, in May 2019 Genus plc partnered with Beijing Capital Agribusiness (BCA) located in China. BCA is expected to assist the company in patented technology applications to develop Porcine Reproductive and Respiratory Syndrome Virus (PrRVS)–resistant animal. in April 2018, Select Sires introduced an Elite sexed fertility product line. The company would identify sires with superior fertility sex-sorted semen using an Elite Sexed Fertility designation, enhancing its product base. Some of the prominent players in the veterinary artificial insemination market include:

  • Swine Genetics International

  • Select Sires, Inc.

  • SEMEX

  • Cooperative Resource International (GENEX)

  • Zoetis

  • Cogent

  • Genus plc

  • Viking Genetics

  • Polar Genetics India

  • Fox Fire Farm

  • Xcell Breeding & Livestock Services Private Limited

Veterinary Artificial Insemination Market Report Scope

Report Attribute

Details

Market size value in 2020

USD 3.95 billion

Revenue forecast in 2027

USD 5.86 billion

Growth Rate

CAGR of 5.78% from 2020 to 2027

Base year for estimation

2019

Historical data

2016 - 2018

Forecast period

2020 - 2027

Quantitative Units

Revenue in USD million and CAGR from 2020 to 2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors and trends

Segments Covered

Product, animal type, end-use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

The U.S.; Canada; The U.K.; Germany; France; Italy; Spain; Russia; Japan; India; China; Australia; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE

Key Companies Profiled

Swine Genetics International; Select Sires, Inc.; SEMEX; Cooperative Resource International (GENEX); Zoetis; Cogent; Genus plc; Viking Genetics; Polar Genetics India; Fox Fire Farm; Xcell Breeding & Livestock Services Private Limited

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country and segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the veterinary artificial insemination market on the basis of animal type, products, end-use, and region:

  • Animal Type Outlook (Revenue, USD Million, 2016 - 2027)

    • Cattle

    • Swine

    • Sheep

    • Canine

    • Equine

    • Others

  • Products Outlook (Revenue, USD Million, 2016 - 2027)

    • Normal Semen

    • Sexed Semen

  • End-use Outlook (Revenue, USD Million, 2016 - 2027)

    • Veterinary Hospitals

    • Animal Husbandry

    • Others

  • Regional Outlook (Revenue, USD Million, 2016 - 2027)

    • North America

      • The U.S.

      • Canada

    • Europe

      • Germany

      • The UK

      • France

      • Italy

      • Spain

      • Russia

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • MEA

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

Pricing & Purchase Options

Service Guarantee

  • Quality assurance

    Insured Buying

    This report has a service guarantee. We stand by our report quality.

  • Information security

    Confidentiality

    We are in compliance with GDPR & CCPR norms. All interactions are confidential.

  • grand view research PCI DSS complaint grand view research gdpr verified
  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities